AATF Synthetic Peptide, PEP-0309, from Invitrogen.
AATF Synthetic Peptide, PEP-0309, from Invitrogen.
The protein encoded by this gene was identified on the basis of its interaction with MAP3K12/DLK, a protein kinase known to be involved in the induction of cell apoptosis. This gene product contains a leucine zipper, which is a characteristic motif of transcription factors, and was shown to exhibit strong transactivation activity when fused to Gal4 DNA binding domain. Overexpression of this gene interfered with MAP3K12 induced apoptosis.
Conservation
Storage: -20°C.
Formulation
Concentration: 200 μg/mL.
Regulatory status
Research only (RUO).
Packaging
Packaging: 50 μg.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15276519 |
| Specifications |
| Gene ID (Enter) | 26574 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9NY61 |
| Common name | Human AATF |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | AATF |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
Origin and customs
| Manufacturer ref. | PEP-0309 |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3824 99 96 00 |
|---|
A question or a specific configuration?
Contact us for a quote.